+Search query
-Structure paper
| Title | Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics. |
|---|---|
| Journal, issue, pages | Rsc Med Chem, Vol. 12, Page 370-379, Year 2020 |
| Publish date | Jul 14, 2020 (structure data deposition date) |
Authors | Oerlemans, R. / Ruiz-Moreno, A.J. / Cong, Y. / Dinesh Kumar, N. / Velasco-Velazquez, M.A. / Neochoritis, C.G. / Smith, J. / Reggiori, F. / Groves, M.R. / Domling, A. |
External links | Rsc Med Chem / PubMed:34041486 |
| Methods | X-ray diffraction |
| Resolution | 2.1 Å |
| Structure data | ![]() PDB-6zrt: ![]() PDB-6zru: |
| Chemicals | ![]() ChemComp-DMS: ![]() ChemComp-SV6: ![]() ChemComp-HOH: ![]() ChemComp-U5G: |
| Source |
|
Keywords | VIRAL PROTEIN / Protease / Telaprevir / inhibitor / Boceprevir |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links






Keywords